Skip to search formSkip to main contentSkip to account menu

acquired hemophilia

Known as: acquired haemophilia 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Recombinant activated factor VII : 30 years of research and innovation
Recombinant activated factor VII (rFVIIa) was initially developed to treat bleeding episodes in patients with congenital… 
Review
2013
Review
2013
Late immune tolerance induction in haemophilia A patients
The incidence of inhibitor development in patients with severe haemophilia A is approximately 30%. Immune tolerance induction… 
2012
2012
Extracorporeal Treatment for the Acute und Long-Term Outcome of Patients with Life-Threatening Acquired Hemophilia
Objectives: In acquired hemophilia (AH), autoantibodies (inhibitors) impede blood coagulation factors leading to severe bleedings… 
2007
2007
Safety and efficacy of a sucrose‐formulated recombinant factor VIII product for the treatment of previously treated patients with haemophilia A in China
Summary.  The use of plasma‐derived products has contributed to a high rate of blood‐borne infections among haemophilia patients… 
2000
2000
Epsilon-Aminocaproic Acid Inhibits the Activity of Factor VIII Inhibitors in Patients with Severe Haemophilia A in vivo and in vitro
Haemophilia patients with inhibitors pose a formidable challenge for patient management. This is particularly problematic in… 
1997
1997
Pharmacokinetics of von Willebrand factor and factor VIII in canine von Willebrand disease and haemophilia A.
1997
1997
Cross-reactivity to porcine factor VIII of factor VIII inhibitors in patients with haemophilia in Australia and New Zealand.
BACKGROUND Inhibitory antibodies which neutralise factor VIII develop in 10-20% of individuals with inherited haemophilia A and… 
1995
1995
Severe haemophilia A in a female resulting from two de novo factor VIII mutations
Summary. A 2‐year‐old girl is described with severe haemophilia A (factor VIII: C <0‐01 units/ml). Both of her parents were… 
1995
1995
The administration of desmopressin by nasal spray: a dose‐determination study in patients with mild haemophilia A or von Willebrand's disease
Desmopressin is an important haemostatic agent in many types of bleeding disorders. The intranasal route for administration of… 
Highly Cited
1991
Highly Cited
1991
Detection of three novel mutations in two haemophilia A patients by rapid screening of whole essential region of factor VIII gene
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)